Koenigstein, Germany

Andreas Kappel

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Königstein, DE (2012)
  • Koenigstein, DE (2013 - 2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Coagulation Diagnostics: The Contributions of Andreas Kappel

Introduction

Andreas Kappel, a dedicated inventor based in Koenigstein, Germany, has made significant contributions to the field of in-vitro diagnostics. With a total of five patents to his name, Kappel's work primarily focuses on methods for determining critical factors involved in blood coagulation. His innovative approaches have the potential to enhance diagnostic accuracy and patient care in healthcare settings.

Latest Patents

Among Kappel's latest patents are two notable inventions:

1. **Method of Determining Factor XIII with the Aid of Plasma-Based Reference Material**: This invention addresses the determination of the blood-clotting factor XIII. Utilizing plasma-based reference materials, Kappel's method aims to improve the reliability and efficiency of in-vitro diagnostics related to coagulation.

2. **Method of Determining Inhibitors of Coagulation**: This patent introduces a homogeneous method to identify inhibitors of proteolytically active coagulation factors, particularly targeting direct thrombin and factor Xa inhibitors. The method features test kits that leverage ligands that effectively bind with coagulation factors, offering a competitive analysis without being cleaved by these factors.

Career Highlights

Andreas Kappel is affiliated with Siemens Healthcare Diagnostics Products GmbH, a company renowned for its advancements in healthcare diagnostics. His work contributes to the development of innovative diagnostic tools that can significantly improve patient outcomes in clinical settings.

Collaborations

Throughout his career, Kappel has collaborated with other professionals in his field, including Gerlinde Christ and Norbert F. Zander. These collaborations have fostered an environment of innovation and research, culminating in the development of cutting-edge diagnostic methods that are instrumental in advancing the understanding of coagulation factors.

Conclusion

Through his inventive spirit and dedication to research, Andreas Kappel has established himself as a key figure in the domain of diagnostic innovations. His patents not only reflect his expertise but also underscore the importance of ongoing research in the science of blood coagulation. As the healthcare industry continues to evolve, Kappel’s contributions will undoubtedly play a crucial role in shaping future diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…